España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
RxSight
RXST
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$47.42
0.01
0.02%
Last update: 9:28 AM
15 minutes delayed
Get Report
Comment
Q2 2024 Earnings in 13 days from now on Mon Aug 5th, after the market close
RxSight (RXST) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for RxSight (NASDAQ:RXST) Stock
RxSight Stock (NASDAQ: RXST)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 16, 2024
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Chris Katje
Monday, July 15, 2024
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Benzinga Insights
BTIG Maintains Buy on RxSight, Raises Price T...
Benzinga Newsdesk
Wednesday, July 10, 2024
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
RxSight shares are trading lower after Stifel...
Benzinga Newsdesk
Stifel Maintains Buy on RxSight, Lowers Price...
Benzinga Newsdesk
Thursday, May 23, 2024
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
Zacks
Thursday, May 09, 2024
Why RxSight (RXST) Shares Are Falling
Henry Khederian
Reported Earlier, RxSight Prices Public Offer...
Benzinga Newsdesk
Wednesday, May 08, 2024
RxSight shares are trading lower after the co...
Benzinga Newsdesk
RxSight Announces $100M Proposed Public Offer...
Benzinga Newsdesk
Tuesday, May 07, 2024
Wells Fargo Maintains Overweight on RxSight, ...
Benzinga Newsdesk
What 10 Analyst Ratings Have To Say About RxSight
Benzinga Insights
RxSight shares are trading higher after the c...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
Needham Maintains Buy on RxSight, Raises Pric...
Benzinga Newsdesk
BTIG Maintains Buy on RxSight, Raises Price T...
Benzinga Newsdesk
Monday, May 06, 2024
RxSight Raises 2024 Revenue Guidance From $12...
Benzinga Newsdesk
RxSight Q1 2024 Adj EPS $(0.12) Beats $(0.27)...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Stifel Maintains Buy on RxSight, Raises Price...
Benzinga Newsdesk
Thursday, April 11, 2024
Assessing RxSight: Insights From 8 Financial Analysts
Benzinga Insights
Needham Reiterates Buy on RxSight, Maintains ...
Benzinga Newsdesk
Thursday, February 29, 2024
Stifel Maintains Buy on RxSight, Raises Price...
Benzinga Newsdesk
JP Morgan Maintains Overweight on RxSight, Ra...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
Forecasting The Future: 9 Analyst Projections For RxSight
Benzinga Insights
Needham Maintains Buy on RxSight, Raises Pric...
Benzinga Newsdesk
Wednesday, February 28, 2024
RxSight Sees FY24 Revenue $128M-$135M Vs $126...
Benzinga Newsdesk
Recap: RxSight Q4 Earnings
Benzinga Insights
RxSight Q4 2023 Adj EPS $(0.13) Beats $(0.36)...
Benzinga Newsdesk
Earnings Scheduled For February 28, 2024
Benzinga Insights
Tuesday, February 27, 2024
RxSight's Earnings Outlook
Benzinga Insights
Monday, February 12, 2024
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
Benzinga Insights
Monday, January 29, 2024
The Analyst Landscape: 8 Takes On RxSight
Benzinga Insights
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
Thursday, January 25, 2024
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
Avi Kapoor
Tuesday, January 16, 2024
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
RXSight shares are trading higher after the c...
Benzinga Newsdesk
Breaking Down RxSight: 5 Analysts Share Their Views
Benzinga Insights
Needham Maintains Buy on RxSight, Raises Pric...
Benzinga Newsdesk
Sunday, January 07, 2024
RxSight, Inc. Announces Preliminary Unaudited...
Benzinga Newsdesk
Wednesday, December 13, 2023
Analyst Expectations for RxSight's Future
Benzinga Insights
Wells Fargo Upgrades RxSight to Overweight, A...
Benzinga Newsdesk
Tuesday, December 12, 2023
Stifel Initiates Coverage On RxSight with Buy...
Benzinga Newsdesk
Monday, December 04, 2023
Morgan Stanley Initiates Coverage On RxSight ...
Benzinga Newsdesk
Friday, November 10, 2023
Needham Maintains Buy on RxSight, Lowers Pric...
Benzinga Newsdesk
Thursday, November 09, 2023
RxSight: Q3 Earnings Insights
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
